Bfsg, LLC Moderna, Inc. Transaction History

Bfsg, LLC

$774 Million
Q2 2024

A detailed history of Bfsg, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Bfsg, LLC holds 20 shares of MRNA stock, worth $1,315. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 20 -0.0%

Holding current value

$1,315

Previous $2,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 01, 2024	BUY	$69.51 - $104.43 $1,390 - $2,088	20 New	20 $1,000
Q4 2021 Jan 24, 2022	SELL	$225.82 - $368.51 $892,892 - $1.46 Million	-3,954 Closed	0 $0
Q3 2021 Nov 03, 2021	BUY	$221.9 - $484.47 $877,392 - $1.92 Million	3,954 New	3,954 $1.52 Million
Q3 2020 Nov 04, 2020	SELL	$54.34 - $94.85 $516,664 - $901,833	-9,508 Closed	0 $0
Q2 2020 Jul 22, 2020	BUY	$29.67 - $80.0 $282,102 - $760,640	9,508 New	9,508 $611,000

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bfsg, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bfsg, LLC with notifications on news.

Account